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Abstract
Leishmaniasis is a neglected disease produced by the intracellular protozoan parasite Leishmania. In the present study, we
show that LABCG2, a new ATP-binding cassette half-transporter (ABCG subfamily) from Leishmania, is involved in parasite
virulence. Down-regulation of LABCG2 function upon expression of an inactive mutant version of this half-transporter
(LABCG2K/M) is shown to reduce the translocation of short-chain analogues of phosphatidylserine (PS). This dominant-
negative phenotype is specific for the headgroup of the phospholipid, as the movement of phospholipid analogues of
phosphatidylcholine, phosphatidylethanolamine or sphingomyelin is not affected. In addition, promastigotes expressing
LABCG2K/M expose less endogenous PS in the stationary phase than control parasites. Transient exposure of PS at the outer
leaflet of the plasma membrane is known to be one of the mechanisms used by Leishmania to infect macrophages and to
silence their immune response. Stationary phase/metacyclic promastigotes expressing LABCG2K/M are less infective for
macrophages and show decreased pathogenesis in a mouse model of cutaneous leishmaniasis. Thus, mice infected with
parasites expressing LABCG2K/M did not develop any lesion and showed significantly lower inflammation and parasite
burden than mice infected with control parasites. Our results indicate that LABCG2 function is required for the
externalization of PS in Leishmania promastigotes, a process that is involved in the virulence of the parasite.
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Introduction
Leishmaniasis is a neglected disease that is caused by different
species of the protozoan parasite Leishmania [1]. This parasite has a
digenetic life cycle in which it alternates between promastigote and
amastigote stages. Inside the insect (sandfly) vector, non-infective
promastigotes are transformed into infective parasites during
metacyclogenesis. After the host is bitten by the sandfly, an intense
neutrophilic infiltrate into the skin bite sites occurs accompanied
by a significant recruitment of macrophages. Afterwards, Leish-
mania metacyclic promastigotes attach to neutrophils as the initial
host cell, and are taken up by phagocytosis [2]. The uptake of
infected neutrophils by macrophages is a mechanism for ‘‘silent’’
entry of parasites into macrophages, where they differentiate into
the replicative amastigote forms that are responsible for mainte-
nance and propagation of the infection in the phagolysosomal
compartment of the mammal host [3,4].
Phosphatidylserine (PS), a phospholipid (PL) normally asym-
metrically confined on the inner leaflet of the plasma membrane of
eukaryotic cells [5], seems to play a critical role in the infection of
macrophages by Leishmania [6–9]. Indeed, PS exposure on the
outer leaflet of the plasma membrane of apoptotic mammalian
cells [10] constitutes the most central ‘‘eat-me’’ signal known for
macrophages, which also ‘‘silent’’ its activity to avoid an
inflammatory reaction [11]. In a process known as apoptotic
mimicry, surface exposure of PS in Leishmania promastigotes and
amastigotes is required for the infection of new mammalian cells
[6,7] and for down-regulation of the microbicidal activity of
macrophages [8,9,12] by inhibiting their nitric oxide production
and increasing IL-10 synthesis and TGFb1 secretion [8,13]. In
addition, the well-characterized higher infectivity of the stationary
phase promastigotes (metacyclic), as compared to the log phase
promastigotes, is also due to the specific exposure of PS on their
surface [14], among others factors including the lipophosphogly-
can (LPG) or the phosphatidylinositol-anchored surface molecule
gp63 [15]. Interestingly, it has been suggested that these PS-
exposing promastigotes could be genuine apoptotic cells destined
for death [12,16] instead of apoptotosis-mimicking parasites.
Indeed, their presence in the virulent inoculum, in an altruistic
behaviour, provides survival advantages for the viable parasites
and is necessary for progress of the disease [16]. Recently, it has
been demonstrated that PS exposure by intracellular amastigotes
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of L. amazonensis is associated with a modified host inflammatory
response, correlating with parasite infectivity and with clinical
parameters of diffuse cutaneous leishmaniasis [17]. Thus, Leish-
mania parasites able to expose higher amounts of PS, induce a
more severe and persistent human disease [17].
The plasma membrane PL asymmetry in eukaryotic cells is
maintained due to the bidirectional transport of PL (flip-flop),
which involves three protein-mediated activities [18]: i) flippases,
which promote active inward-directed PL migration, mediated by
aminophospholipid translocases (APT); ii) floppases, which are
responsible for the active outward transport of PL from the
cytoplasmic to the exoplasmic leaflet of the membrane, mediated
by various ATP-binding cassette (ABC) transporters; and iii)
scramblases, which are translocases that not require ATP to
equilibrate the PL between the two membrane bilayers. PS
externalization in apoptotic cells has been suggested to be due to i)
a scramblases activity, enhanced by loss of the APT function [19];
and ii) to a higher activity of ABC efflux pumps such as ABCA1
[20]. Additionally, it has been suggested that PS is also delivered to
the surface of lysosomes that fuse with the plasma membrane
during apoptosis [21]. In the case of Leishmania, a decrease in the
active out-to-in PS translocation, thus allowing ATP-independent
PS movement, has also been suggested to be responsible for the
loss of PL asymmetry [14]. However, disruption of the plasma
membrane APT of Leishmania (LdMT) does not lead to an
increased infectivity [22,23]. In addition, although a scramblase
activity has been described in Leishmania, its role in parasite
infectivity remains to be elucidated [24]. The molecular basis of
PS exposure in Leishmania therefore remains unsolved.
Functional ABC transporters consists of two homologous halves,
each of which is composed of a transmembrane domain (TMD),
which is involved in substrate binding and a cytosolic nucleotide
binding domain (NBD), which hydrolyses ATP to provide the
energy required for the transport [25]. The ATP sites are
reconstituted upon dimerization of both NBDs, which pack
together in a head-to-tail configuration to generate two ATP
binding and hydrolysis sites between the conserved Walker A and
B motifs of one NBD and the signature motif of the other [26].
ABC half-transporters with a single NBD therefore require
homo-/heterodimerization to reconstitute the ATP sites. Members
of the ABCA, ABCB and ABCG human subfamilies have been
implicated in PL translocation [18,27]. For example, human
ABCG2 (BCRP/MXR/ABCP), a protein involved in multidrug
resistance in cancer cells [28,29], is responsible for enhanced
exposure of PS at the plasma membrane of ABCG2 overexpress-
ing cells due to increased outward PS transport [30]. Members of
the ABCG subfamily of half-transporters have been identified in
Leishmania [31], and three of these have already been functionally
characterized. Thus, LABCG4 is localized at the plasma
membrane of the parasite and is involved in the translocation of
phosphatidylcholine (PC) analogues; it also confers resistance to
alkyl phospholipids [32]. LABCG6 is also localized at the plasma
membrane and is probably involved in PL trafficking as it reduces
the accumulation of PL analogues of PC, phosphatidylethanol-
amine (PE) and PS [33], and confers resistance to camptothecin
[34], miltefosine and sitamaquine [33]. LABCG5, in contrast, is
not involved in the translocation of PL at the plasma membrane or
drug resistance but participates in salvage of the heme released
after the breakdown of internalized haemoglobin [35]. Addition-
ally, it has been reported that other Leishmania ABC transporters
such as LABCB4 [36], LABCA1 [37] and LABCA2 [38] are
involved in PL translocation.
The aim of our work was to study the functionality of the
transporter LABCG2 from Leishmania, specifically its involvement
in PS translocation and its implication in parasite virulence. The
results show that down-regulation of LABCG2 produces a defect
in the exposure of endogenous PS at the external surface of the
parasite, and that this defect correlates with a significant decrease
in the ability of these parasites to infect mouse peritoneal
macrophages and to produce pathology in a mouse model of
cutaneous leishmaniasis.
Materials and Methods
Materials
3-(4,5-Dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide
(MTT), PMSF (phenylmethylsulfonyl fluoride), DFP (diisopropyl-
fluorophosphate), monoclonal anti a-tubulin, and amphotericin B
were obtained from Sigma Chemical Company (St. Louis, USA).
Anti-histone H2A was courtesy of Dr. Stephen M. Beverley
(Washington University, School of Medicine, St. Louis, Missouri,
USA). Polyclonal anti-GFP antibody was from Rockland Compa-
ny. Mouse monoclonal anti-gp63 was from Life Span BioSciences.
Polyclonal antisera against metacyclic marker protein HASPB was
a kind gift from Dr. Deborah F. Smith (University of York, UK).
The fluorescent analogues 1-palmitoyl-2-[6-(7-nitrobenz-2-
oxa-1,3-diazol-4-yl)amino]hexanoyl-sn-glycero-3-phosphocholine
(NBD-PC), -phosphoethanolamine (NBD-PE), -phosphoserine
(NBD-PS) and 6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino-hexa-
noyl-sphingosine-1 phosphocholine (NBD-sphingomyelin; NBD-
SM) were purchased from Avanti Polar Lipids (Birmingham, AL,
USA). Annexin V-Alexa 488, FM4-64, concanavalin A-Alexa
Red, MitoTracker Deep Red 633, Cell Tracker TM Green and
DAPI were from Molecular Probes (Invitrogen, Carlsbad, CA).
Ro-peptide (Ro09-0198), a tetracyclic peptide antibiotic, was
kindly provided by Dr. Masato Umeda (The Tokyo Metropolitan
Institute of Medical Science, Japan). Papuamide B (Flintbox,
LynseyHuxham), a novel depsipeptide obtained from extracts of
marine sponges, was kindly provided by Dr. Thomas Gunther
Pomorski and Dr. Rosa Lo´pez (Department of Plan Biology and
Biotechnology, University of Copenhagen, Denmark). Peanut
agglutinin (PNA) and fluorescein-conjugated ricin agglutinin was
purchased from Vector (Burlingame, CA). The plasmids
Author Summary
Leishmania is a protozoan parasite that infects human
macrophages, producing the neglected tropical disease
known as leishmaniasis. As is the case for apoptotic cells,
transient exposure of phosphatidylserine (PS) on the
surface of the parasite is required for macrophage
engulfment and infection. Although the mechanism
involved in this lipid translocation remains unknown,
inhibition of PS exposure could therefore prove to be a
novel way to combat this parasitic disease. Here, we have
identified a new ABC transporter from Leishmania, namely
LABCG2, as a protein involved in this process. The
dominant-negative inhibition of LABCG2 showed that this
transporter is required for the normal exposure of PS on
the outer leaflet of the plasma membrane. This altered
phenotype was subsequently found to be correlated with
a deficient ability to infect mouse peritoneal macrophages.
In addition, studies in a mouse model of cutaneous
leishmaniasis showed that animals infected with parasites
with down-regulated LABCG2 activity did not develop any
lesions. Taken together, these results suggest a role for the
Leishmania LABCG2 transporter in PS exposure, determin-
ing the virulence of the parasite.
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pXG-GFP+29 and pXG-’GFP, which can be used to express GFP
fusion proteins in Leishmania with GFP at either the N- or the C-
terminus, respectively, were kindly provided by Dr. Stephen M.
Beverley.
Leishmania strains and cell cultures
Promastigote forms of Leishmania major clone V1 (MHOM/IL/
80/Friedlin), Leishmania infantum (MHOM/ES/1993/BCN-99)
and Leishmania donovani (MHOM/ET/67/HU3) were maintained
in vitro at 28uC in modified RPMI-1640 medium (Invitrogen,
Carlsbad, CA) supplemented with 20% heat-inactivated foetal
bovine serum (hiFBS, Invitrogen), as described previously [37,38].
To determine parasite sensitivity to the toxic peptides papuamide
B and Ro-peptide, and to amphotericin B, 106/mL parasites were
incubated in RPMI-1640 containing different concentrations of
peptides and the parasite viability determined by MTT analysis
after 72 h, as described previously [39].
DNA constructs and cell transfection
LABCG2 (GeneDB-L. major, Accession Code LmjF06.0090) was
isolated from the genomic DNA of L. major by PCR using sense (59-
ATATCGCTGTCTCTGCGTCG) and antisense (59- GGCA-
AACACACAGAGCGATG) primers. The nucleotide sequences
were determined automatically as previously described [40]. To
obtain parasites expressing non-functional LABCG2, a mutation
was introduced in the Walker A motif of the ATP binding domain,
replacing lysine 108 with a methionine (K108M) using the
QuikChange XL Site-Directed Mutagenesis kit (Stratagene, La
Jolla, CA). The resulting mutated gene LABCG2K108M
(LABCG2K/M) was cloned into the Leishmania expression vector
pUCNeoPlus [37]. The vector pXG-GFP+29 was used to create
GFP- LABCG2 and -LABCG2K/M versions with GFP fusions at
N-terminus [41]. The LABCG2 and LABCG2K/M open reading
frame for these N-terminus tagged versions was amplified by PCR
using sense (59-GCGGCCGCATGCCCCCTCCCGCAGCAA-
CACGTGC) and antisense (59-GCGGCCGCTCATGCC-
GTTCTCGCACAGCTCGCCA) primers. For the C-terminus
tagged versions, LABCG2 and LABCG2K/M were cloned in a
pXG-’GFP+ using sense (59-ACCGGTATGCCCCCTCCCG-
CAGCAACACGTGC) and antisense (59- GATATCTGCCGTT-
CTCGCACAGCTCGCCACGG) primers. Promastigotes of L.
major were transfected with the different constructs and selected for
G-418 resistance as described previously [42].
Gene expression analysis
Total RNA was prepared from control (empty vector) and
LABCG2K/M expressing promastigotes using the total RNA
isolation kit (Roche Biochemicals). cDNA was synthesized from
60 ng of total RNA using Superscript II TM RNaseH Reverse
Transcriptase (Invitrogen) and oligo (dT)12–18 primers (Invitro-
gen) following the manufacturer’s instructions. Semi-quantitative
PCR was performed with 50 mL aliquots using 50 pmol each of
sense and antisense primers corresponding to LABCG2 and
LmGAPDH using the following profile: initial denaturation at
95uC for 5 min followed by 25 cycles with denaturation at 95uC
for 1 min, annealing at 54uC for 30 s and extension at 68uC for
35 s, with a final extension of 5 min.
Fluorescence microscopy of Leishmania promastigotes
For endosome/lysosomal labelling, 107 stationary-phase pro-
mastigotes obtained after 4 day culture were incubated in 1 mL of
RPMI 1640 medium containing 50 mg/mL of concanavalin A-
Alexa Red for 2 h at 28uC or with 1 mM FM4-64 for 30 min at
28uC or 4uC. For mitochondrial labelling, 107 stationary-phase
promastigotes were stained with 50 nM MitoTracker Deep Red
633 for 30 min at 28uC and then washed in ice-cold phosphate-
buffered saline (PBS; 1.2 mM KH2PO4, 8.1 mM Na2HPO4,
130 mM NaCl and 2.6 mM KCl adjusted to pH 7). Parasites were
fixed for 30 min at 4uC with 2% paraformaldehyde and then
observed under a microscope. Images (one stack) were acquired
using an Olympus IX81 microscope and deconvolved using
Huygens Professional.
Analysis of fluorescent PL uptake
The NBD-phospholipid accumulation was determined by flow
cytometry as described previously [43]. Briefly, stationary-phase
promastigotes (107/mL) were incubated in HPMI buffer (20 mM
HEPES, 132 mM NaCl, 3.5 mM KCl, 0.5 mM MgCl2, 5 mM
glucose, 1 mM CaCl2, pH 7.4) supplemented with 0.3% (w/v)
BSA for 30 min at 28uC, then labelled with 10 mM NBD-PC,
10 mM NBD-PE, 10 mM NBD-SM or 30 mM NBD-PS for 30 min
at 28uC. HPMI was supplemented with either 500 mM PMSF or
5 mM DFP to block the catabolism of NBD-lipids [43]. Parasites
were washed twice with ice-cold PBS, supplemented with 0.3%
BSA and resuspended in PBS for flow cytometry analysis, using a
Beckton Dickinson FACScan (San Jose´, CA) equipped with an
argon laser operating at 488 nm.
Measurement of NBD-PS outward transport in L. major
lines
To measure the NBD-PS outward transport from the cytoplas-
mic to the exoplasmic leaflet, Leishmania stationary-phase promas-
tigotes (107/ml) were labeled with 30 mM (control parasites) or
15 mM (LABCG2K/M) NBD-PS for 30 min at 28uC in HPMI
buffer (20 mM HEPES, 132 mM NaCl, 3.5 mM KCl, 0.5 mM
MgCl2, 5 mM glucose, 1 mM CaCl2, pH 7.4) supplemented with
0.1% (w/v) BSA to allow that inward movement of the NBD
analogue was equally, as previously described [30]. Afterwards,
NBD-PS remaining on the cell surface was extracted twice by
incubation with 2% (w/v) BSA in HPMI (supplemented with
5 mM glucose and 500 mM PMSF) for 5 min on ice. Before
starting the outward transport assay, the medium was removed
and parasites were washed with ice-cold PBS. For t=0 min, the
cells were resuspended in HPMI (supplemented with 2% BSA,
5 mM glucose and 500 mM PMSF). Time dependent outward
transport was monitored at 28uC at different time points (5, 15, 30,
60 min) in the supernatants and the samples were analyzed by
SLM-Aminco 8000C spectrofluorimeter.
Annexin V- binding assay
Leishmania promastigotes were harvested in RPMI-1640 and
centrifuged at 25006 g for 10 min at 4uC. The cells were washed
with Annexin V-binding buffer (20 mM HEPES, 132 mM NaCl,
3.5 mM KCl, 5 mM CaCl2 and 0.5 mM MgCl2, pH 7.4 and
10 mM glucose), then resuspended in the same buffer and
incubated with Annexin V–Alexa 488 (1/20 dilution; at the
concentration indicated by the manufacturer) at 4uC for 15 min.
The parasites were subsequently labelled with propidium iodide
(0.4 mg/ml) and the mixture incubated for 5 min at 4uC. The cells
were washed for 1 min at 25006 g and 4uC, and resuspended to a
cell density of 46106 cells/mL. Controls measurements in the
absence of calcium were included using Annexin V–Alexa 488
plus 8 mM EGTA. Cellular fluorescence was quantified by
scanning the emission in a FACSCalibur and analysed using the
Cell Quest Pro software application. A total of 10,000 events were
harvested from each sample. The control cells were incubated in
Leishmania Infectivity Involves an ABC Transporter
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Annexin V-binding buffer alone, without Annexin V–Alexa 488,
under identical conditions.
In vitro infection of mouse peritoneal macrophages
Peritoneal macrophages from BALB/c mice (Charles River Ltd.)
were harvested by lavage with ice-cold RPMI 1640 medium, plated
at a density of 56105 macrophages/well in RPMI-1640 medium plus
10% hiFBS in 24-well plates provided with glass coverslips (22 mm2)
and allowed to adhere for 4 h at 37uC under 5% CO2, as described
previously [7,8]. The adherent macrophages were infected at 35uC
with stationary-phase promastigotes of control and LABCG2K/M-
expressing L. major parasites with or without Annexin V (0.05 mg/
ml6107promastigotes), at a parasite-to-cell ratio of 5:1 in RPMI-1640
medium supplemented with 5% hiFBS. After 4 h of infection,
unphagocytosed parasites were removed by washing with serum-free
medium. The infected macrophages were further incubated in RPMI
1640 medium supplemented with 10% hiFBS for 24 h at 37uC in a
5% CO2 atmosphere. Following incubation, the cultures were fixed
with 2% paraformaldehyde/glucose, stained with DAPI and the rate
of infected macrophage analyzed using images acquired with an
Olympus IX81 microscope as described previously [44]. Parasites
were quantified using a cell counter provide with the Image J software
(http://rsb.info.nih.gov/ij/). The images were deconvolved using
Huygens Professional from Scientific Volume Imaging (http://www.
svi.nl). The percentage of macrophage infection was calculated by
dividing the number of infected macrophages by the number of
counted macrophages. The mean number of amastigotes per infected
macrophage was determined by dividing the total number of
amastigotes counted by the number of infected macrophages. Three
independent experiments were performed with duplicates.
Leishmania binding assays
The interactions between L. major stationary-phase promasti-
gotes and mouse peritoneal macrophages were measured as
previously described with some modifications [22]. Mouse
peritoneal macrophages (56105/well), maintained at 37uC with
5% CO2 in RPMI 1640 medium supplemented with 10% of
hiFBS, were labeled with 5 mM FM4-64 for 30 min at RT in
RPMI 1640 medium. LABCG2K/M and control L. major
promastigotes (107/ml) in stationary phase were labeled with
1 mM Cell Tracker TM Green for 40 min at 28uC in RPMI 1640
medium. Then, parasites and peritoneal macrophages were
washed four times in RPMI 1640 medium and finally resuspended
in RPMI 1640 medium supplemented with 5% of hiFBS. Binding
assays were performed using a parasite:macrophage ratio of 5:1.
Promastigote forms of L. major lines were added to the monolayer
cells. After 4 h incubation at 37uC, unbound promastigotes were
removed by thorough washing. The monolayers and bound
promastigotes were analysed by a Confocal Leyca SP5 microsco-
py. All the experiments were done in triplicate.
LPG and gp63 surface expression analysis
Expression analysis of the surface molecule LPG was performed
as described previously [45]. Thus, stationary-phase promastigotes
(107/mL) were washed twice with PBS and incubated with 5 mg/
mL fluorescein-conjugated ricin agglutinin in PBS for 10 min at
28uC, then washed with PBS and analyzed by flow cytometry
using a FACSCalibur (Beckton Dickinson). For quantification of
cell surface gp63, parasites were incubated with a 1:500 dilution of
a mouse monoclonal anti-gp63 on ice. The cells were subsequently
washed with PBS supplemented with 0.1% BSA and fixed at 4uC
in 2% paraformaldehyde for 20 min, then washed again and
incubated at room temperature with a 1:500 dilution of FITC
fluorescein isothiocyanate-labeled goat anti-mouse immunoglobu-
lin G (Sigma). These cells were washed three times with PBS-0.1%
BSA and the parasite-associated fluorescence was analyzed by flow
cytometry using a FACSCalibur.
Metacyclic purification assay
Metacyclic promastigotes were isolated from stationary cultures of L.
major promastigotes by negative selection using a previously described
peanut agglutinin (PNA) methodology [46]. Briefly, stationary-phase
promastigotes were collected after culture for 4 days, washed with PBS
and then incubated with 100 mg/mL of PNA. After incubation for
10 min at room temperature, cells were separated by centrifugation at
5006 g for 10 min. The non-agglutinated promastigotes (metacyclic)
collected in the supernatant were washed twice with PBS and
resuspended in PBS for further experiments.
Western blot analysis
Proteins from whole stationary-phase promastigotes (107/well)
were resolved in 10% SDS-PAGE and electroblotted onto PVDF
membranes. Western blot analysis was performed as described
previously [47], using a polyclonal antibody against metacyclic
promastigote protein HASPB (1:2000) or GFP (1:5000; Invitro-
gen), followed by detection with a horseradish peroxidase-
conjugated secondary goat anti-rabbit IgG (1:5000; Dako Den-
mark) antibody. Monoclonal antibodies against H2A histone or a-
tubulin (1:5000 or 1:10000; Sigma-Aldrich) were used to confirm
equivalent protein loading. Detection was carried out by enhanced
chemiluminescence reaction using the ECL kit (Amersham).
Analysis of in vivo infection
Six-week-old female BALB/c mice were purchased from Charles
River Breeding Laboratories and maintained in the Animal Facility
Service of our Institute under pathogen-free conditions. Animals (10
mice/group) were injected subcutaneously in their left hind footpads
with 104 L. major purified metacyclic promastigotes resuspended in
PBS, as described above. Disease progression was monitored by
measuring the inflammation edema and the area of the cutaneous
lesion of the infected footpad using a digital caliper (Mitutoyo,
Japan), in comparison with the values obtained in the uninfected
contralateral footpad. Parasite burdens in target tissues were
determined from the presence of amastigotes isolated from footpad,
spleen and lymph nodes at week five post-infection, after tissue
homogeneization and culture in promastigote culture medium,
using a limiting dilution assay, as described previously [48].
Ethics statement
All experiments were performed according to the National/EU
Guidelines for the Care and Use of Laboratory Animals in
Research and the approval of the Ethics Committee of the Spanish
National Research Council (CSIC, file CEA-213-1-11).
Statistical analysis
Statistical comparisons between groups were performed using
Student’s t test. Differences were considered significant at a level
p,0.05.
Results
Sequence features of LABCG2 and generation of a
Leishmania line expressing an inactive version of the
protein
LABCG2 (GeneDB-L. major, accession code LmjF06.0090) has
two additional tandem imperfect repeats in chromosome 6 of
Leishmania (LABCG1, accession code LmjF06.0080, and
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Figure 1. LABCG2 localizes to the intracellular vesicles of Leishmania parasites. L. major stationary promastigotes transfected with GFP-
LABCG2 (A and C) and GFP-LABCG2K/M (B and D) were incubated at 28uC with 1 mM FM4-64 (A and B) and 50 mg/mL concanavalin A-Alexa Red (C and
D) for 30 min and 120 min, respectively. (E) LABCG2K/M localizes into the flagellar pocket of Leishmania parasites. L. major stationary promastigotes
Leishmania Infectivity Involves an ABC Transporter
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LABCG3, accession code LmjF06.0100) [31]. LABCG1,
LABCG2 and LABCG3 are ‘‘half-transporters’’ with a single
NBD and a single TMD localized at their C-terminus (Appendix
in Supporting information, Fig. S1A). LABCG1 and LABCG2 codes
for a 657 and 663 amino acid protein, with a predicted molecular
weight of approximately 73.4 and 74.0 kDa, respectively.
LABCG1 and LABCG2 are almost identical (95.7% of identity).
LABCG3 protein is truncated, with Walker A and several
transmembrane segments being absent (Appendix in Supporting
information, Fig. S1B). LABCG2 shares 19.5% amino acid
identity with human ABCG1, 24.6% with human ABCG2 and
27.3% with the White protein from Drosophila [35].
The dimerization requirement for ABC half-transporters (such
as LABCG2) to become functional led us to test a dominant-
negative approach to down-regulate LABCG2 function, as
recently described for Leishmania LABCG5 [35]. To this end, we
first mutated in LABCG2 the lysine residue inside the Walker A
motif (108 position), which is known to be critical for ATP
hydrolysis in ABC transporters [35,49], to a methionine (K108M).
The expression of other ABCG half-transporters with a similar K/
M substitution produces a dominant-negative inhibition in the
wild-type transporters [35,50]. The resulting construct was
transfected into L. major and the expression of LABCG2K108M
(LABCG2K/M) was verified by RT-PCR (Appendix in Supporting
information, Fig. S2A). In contrast to the phenotype observed after
LABCG5K/M expression [35], parasites transfected with
LABCG2K/M grew at normal rates (Appendix in Supporting
information, Fig. S2B).
Subcellular localization of LABCG2
To study the localization of LABCG2, we fused LABCG2 and
LABCG2K/M with an N-terminal GFP-tag. These constructs were
transfected into L. major promastigotes and expression of these
proteins determined by Western-blot analysis of whole parasite
lysates. As expected, a band corresponding to GFP-LABCG2 was
observed at around 100 kDa (Appendix in Supporting informa-
tion, Fig. S3A). Additional higher molecular weight signals could
correspond to dimeric forms of the protein, as described for
LABCG5 [35], whereas the lower bands probably correspond to
degraded proteins.
Fluorescence microscopy studies showed that GFP-LABCG2
partially overlap with the endosomal markers FM4-64 [51] and
concanavalin A [52] in the stationary growth phase promastigotes,
which is depicted in representative micrographs in Fig. 1A and 1C.
In contrast, the stained vesicular structures do not co-localize with
the mitochondrial marker MitoTracker (data not shown). The
localization pattern of the protein does not change when GFP-
LABCG2K/M was expressed in Leishmania parasites (Fig. 1B and
1D). To evaluate whether GFP-LABCG2 was also localized in the
flagellar pocket, the sole site for endo-/exocytosis in Leishmania, we
subsequently performed the co-localization experiments with
FM4-64 at 4uC to block its vesicular trafficking. The results
showed that GFP-LABCG2K/M co-localizes in the flagellar pocket
of the stationary-phase promastigotes (Fig. 1E, yellow arrows).
Another part of the GFP-LABCG2K/M pool was detected in
intracellular vesicles localized in the apical part of the cell, at the
tip of the aflagellar pole of the parasite (Fig. 1E), a site that is
known to be involved in the interaction with host cells [53]. GFP-
tagged LABCG2 protein at the COOH-terminal showed a similar
pattern of localization (Appendix in Supporting information,
Fig. S3B), but its expression was unstable after few culture
passages, thus suggesting that the C-terminal TMD region is
critical for maintaining LABCG2 stability. Overall, these studies
suggest that LABCG2 localizes to intracellular vesicles of the
endosomal pathway, at the flagellar pocket and at the aflagellar
pole of Leishmania.
LABCG2 is involved in the exposure of PS on the outer
surface of Leishmania
To study the possible role of LABCG2 in PL transport, we first
investigated the accumulation level of fluorescent short-chain PL
analogues by flow cytometry. Thus, stationary-phase L. major
promastigotes transfected with the empty vector (control) or the
vector containing LABCG2K/M (LABCG2K/M parasites) were
incubated with NBD-PE, -PC, -PS and -SM, and the cell-
associated fluorescence analyzed by flow cytometry after back-
exchange with BSA to extract the NBD-PL located in the outer
plasma membrane leaflet. Under these conditions, accumulation
of NBD-PS by the LABCG2K/M parasites was significantly higher
than that observed for control cells (4.2 fold, n= 12, p,0.05;
Fig. 2A). In contrast, no significant differences were observed for
NBD-PC, NBD-PE and NBD-SM accumulation between control
and LABCG2K/M parasites (Fig. 2B–D). The change in NBD-PS
accumulation was not due to differences in endocytosis, as the
internalization of NBD-SM, which is taken up by this process, was
not affected by the functionality of LABCG2 (Fig. 2D). The above
results were validated in a second transfection event with
LABCG2K/M (Fig. 2E). To verify that the higher NBD-PS
accumulation observed was due to the dominant-negative
inhibition of LABCG2 activity, LABCG2K/M parasites were
cured for the plasmid pUCNeoplusLABCG2K/M (reverted line)
by culturing the parasites in the absence of plasmid drug selection
pressure for three months. This reverted line showed a similar
NBD-PS accumulation to the control line (Fig. 2F). We
subsequently tested whether LABCG2 was involved in NBD-PS
internalization in two other Leishmania species (L. infantum and L.
donovani). Down-regulation of LABCG2 function was also assayed
by expressing LABCG2K/M and a similar phenotype was observed
in these Leishmania species (Appendix in Supporting information,
Fig. S4A and B). To confirm that the higher accumulation of
NBD-PS in the LABCG2K/M parasites was due to a reduced
floppase activity, we measured the outward translocation of NBD-
PS from the cytoplasmic to the exoplasmic leaflet of the plasma
membrane in both Leishmania lines. Thus, control and
LABCG2K/M L. major promastigotes were loaded under conditions
that yielded similar amounts of intracellular NBD-PS after the
back-exchange step. Then, parasites were maintained in probe-
free culture medium containing BSA and the amount of NBD-PS
extracted from the external side of the plasma membrane was
measured at different time points. The results showed that the
outward translocation of NBD-PS was higher in control versus
LABCG2K/M promastigotes (Fig. 2G) suggesting a PS floppase
activity of LABCG2.
Next, we studied the translocation of endogenous, long-chain
PS labelling control and LABCG2K/M stationary growth phase
promastigotes with Annexin V-Alexa Fluor 488. This probe binds
transfected with GFP-LABCG2K/M were incubated with 1 mM FM4-64 for 30 min at 4uC. The parasites were fixed for 10 min in 2% with
paraformaldehyde at 4uC. (a) Nomarski images of b, c, d and e. Representative co-localization sites (f) are indicated by yellow arrows in the merged
images. Scale bar: 5 mm. N (nucleus) and K (kinetoplast) are stained with DAPI. FP: flagellar pocket; AP: aflagellar pole. The figure illustrates a
representative parasite of a total population of parasites with a similar fluorescence pattern.
doi:10.1371/journal.pntd.0002179.g001
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PS exposed in mammalian apoptotic cells [8] and Leishmania
promastigotes in a calcium dependent manner [16] (Appendix in
Supporting information, Fig. S5). Quantitative analysis by flow
cytometer (Fig. 3A) showed that LABCG2K/M parasites presented
a significantly reduced exposure of PS in the outer leaflet of the
plasma membrane compared with control cells (20.1% vs. 52.7%
of Annexin V positive/propidium iodide negative, respectively,
p,0.05). Additionally, we determined that the density of PS
molecules on the cell surface is significantly higher in the control
(53.3566.12) than in the LABCG2K/M parasites (38.1063.49), as
measured by the mean fluorescence intensity (Fig. 3B); however,
control and LABCG2K/M log phase parasites showed a low and
similar Annexin V-binding (10.97% vs. 11.06% of Annexin V
positive/propidium iodide negative, respectively, p,0.05; data not
shown). These results were supported by RT-PCR analysis of
expression of LABCG2 through the life cycle of L major that shows
higher expression of LABCG2 in stationary growth phase/
metacyclic promastigotes versus log phase parasites (Fig. 3C and
3D). To validate that the differences in Annexin V-Alexa Fluor
488 labelling were due to a defect in PS exposure, we tested the
sensitivity of control and LABCG2K/M parasites to papuamide B,
a pore-forming cytolytic peptide that specifically binds to PS at the
external surface of the plasma membrane [54]. The results showed
that LABCG2K/M parasites were less sensitive to papuamide B
than controls (EC50 = 3.2660.67 mM vs. EC50 = 2.1260.33 mM,
p,0.05, respectively) (Fig. 4A). As a control experiment, we tested
the sensitivity of both lines to Ro-peptide, which strictly recognizes
PE residues at the external surface of biological membranes [55].
The results of this study indicated that there were no differences in
sensitivity between LABCG2K/M and control parasites
(EC50 = 1.5860.09 mM vs. EC50 = 1.6460.12 mM, respectively)
(Fig. 4B). These results are in agreement with the absence of
Figure 2. Fluorescent PL accumulation in Leishmania parasites. Stationary promastigotes of Leishmania were incubated with the fluorescent
PL analogues NBD-PS (A), NBD-PC (B), NBD-PE (C) or NBD-SM (D) for 30 min at 28uC. After washing and back-exchange with BSA, cell-associated
fluorescence was measured by flow cytometry analysis. The grey histogram represents control cells transfected with the empty vector, the
uncoloured histogram represents parasites expressing LABCG2K/M and the dotted histogram represents non-labelled cells. (E) NBD-PS accumulation
in Leishmania lines after a second transfection event. The reverted line (F), which was maintained for 3 months without drug pressure, was also
included. The histograms correspond to a representative experiment from three independent experiments. (G) Outward transport of NBD-PS in
Leishmania parasites. Stationary promastigotes of control (black circles) and LABCG2K/M (black squares) Leishmania lines were incubated with the
fluorescent analogue NBD-PS for 30 min at 28uC. After washing and back-exchange with BSA, cells were incubated for different time points in a free
NBD-PS medium containing BSA and the fluorescence of the supernatant was measured by spectrofluorimetry. Results represent the means 6 SD of
four independent duplicated experiments. * P,0.05 vs. control parasites.
doi:10.1371/journal.pntd.0002179.g002
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alterations in NBD-PE translocation in LABCG2K/M parasites.
Several ABCG transporters have been implicated in sterol
transport [56]. Thus, differences in papuamide B sensitivity might
be indirectly caused by a general change in membrane lipid
organization in LABCG2K/M parasites. We study this possibility
by analyzing both sensitivity of control and LABCG2K/M parasites
to amphotericin B; the results shown that there were no significant
differences in sensitivity of both lines to amphotericin B (Fig. 4C),
suggesting that LABCG2 does not contribute greatly in the
distribution of sterols into the plasma membrane. Finally, we
confirmed that the parasites expressing GFP-LABCG2K/M used
for the subcellular localization analysis also maintained their
papuamide B resistance phenotype (data not shown).
Down-regulation of LABCG2 function decreases in vitro
parasite infectivity
As PS externalization by the parasite is a key mediator for infection
of the macrophages [12] and polymorphonuclear cells [16], we
evaluated whether down-regulation of LABCG2 function correlated
with a decreased infectivity of the parasites. Thus, we measured the
ability of control and LABCG2K/M stationary-phase promastigotes to
infect mouse peritoneal macrophages. The results showed that
whereas 80% of macrophages were infected by control parasites after
24 h post-infection, only 20% of cells were infected by LABCG2K/M
parasites (Fig. 5A). In contrast, the number of parasites per infected
macrophage was similar in both cases (Fig. 5B). We have shown that
the different infectivity values observed in LABCG2K/M parasites are
not due to differences in the interaction parasite-macrophages as
determined after 4 hours post-infection binding assays (Appendix in
Supporting information, Fig. S6A and B. The results showed there
were not differences in the percentage of interaction in control cells
(80.5065.77) compared with LABCG2K/M parasites (84.3367.35).
Additionally, we have determined that the overexpression of
LABCG2 in Leishmania parasites did not show differences in the PS
exposition nor in the % infectivity of mouse peritoneal macrophages
(data not shown).
Figure 3. The externalization of endogenous PS by stationary Leishmania promastigotes depends on LABCG2 function. (A) PS
exposure at the outer leaflet of the parasite plasma membrane was analyzed by flow cytometry using Annexin V–Alexa 488 as described in Materials
and Methods. The lower right quadrant in the density plots represents the percentage of Annexin V positive/Propidium iodide negative in control or
LABCG2K/M parasites. Markers were placed using non-stained parasites. (B) Density of PS molecules (GeoMean) on the cell surface. The grey histogram
represents control cells transfected with the empty vector, the uncoloured histogram represents parasites expressing LABCG2K/M and the dotted
histogram represents non-labelled cells. The results shown are representative of three independent duplicated experiments. (C and D) Gene
expression analysis of LABCG2 from L. major control determined by RT-PCR analysis through the different growth phases of Leishmania parasites:
early log (day 2), late log (day 3), stationary (day 4) and late stationary phase (day 5). RT-PCR was carried out for 35 cycles using RNA isolated from the
above parasites and the products were run in 2% agarose gel as described in Materials and Methods. Lower imagine in C shows the expression of
GADPH used as internal loading control. The arrows indicate amplified 280 bp LABCG2 fragment and 227 bp GADPH fragment. Lower imagine in D
shows the mRNA level of LABCG2 normalized with GADPH in different points of the growth curve. The results shown are the means of three
independent experiments 6 SD.
doi:10.1371/journal.pntd.0002179.g003
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We have repeated the infection experiments masking most of
the PS in the metacyclic forms by incubating stationary-phase
control and LABCG2K/M parasites with Annexin V. As expected,
PS masking reduced the macrophage infection percentage of
control parasites by approximately 82%. Annexin V-mediated
masking of PS in LABCG2K/M parasites did not significantly
altered their lower ability to infect peritoneal macrophages,
reaching similar values to those obtained with Annexin V treated
control parasites (Fig. 5C). Furthermore, we assessed whether
other molecules, such as lipophosphoglycan (LPG) or the
phosphatidylinositol-anchored surface molecule gp63 [15], both
of which are implicated in Leishmania infectivity, could be altered in
LABCG2K/M parasites. Flow cytometry analysis of stationary-
phase promastigotes marked with fluorescein-conjugated ricin
agglutinin, which specifically label LPG [45], showed no
differences between control and LABCG2K/M parasites (Appendix
in Supporting information, Fig. S6C). Additionally, flow cytometry
analysis using a specific monoclonal antibody for Leishmania gp63
showed no significant differences between expression of this
surface molecule in the control and LABCG2K/M stationary-phase
promastigotes (Appendix in Supporting information, Fig. S6D).
Finally, we evaluated whether the infectivity differences observed
may be due to an alteration in the metacyclogenesis of the
parasites produced by down-regulation of LABCG2 function.
Thus, we purified infective metacyclic forms from stationary-phase
promastigotes of control and LABCG2K/M parasites by binding to
the lectin peanut agglutinin (PNA) [57], and found that the
percentage of metacyclic parasites (PNA2) obtained was similar in
both cell lines (Appendix in Supporting information, Fig. S7A).
Furthermore, both parasite lines were morphologically elongated,
highly mobile, there were no rounded shapes and differences in
size (FSC-H) between control (427.26613.82) and LABCG2K/M
(413.61614.53) lines, respectively (Appendix in Supporting
information, Fig. S7B). We also analysed expression of the
metacyclic marker protein HASPB (hydrophilic acylated surface
protein B) [58], which is implicated in host-cell infection. Western
blot analysis indicated that there were no differences in expression
of this 32 kDa protein between control and LABCG2K/M
parasites (Appendix in Supporting information, Fig. S7C).
LABCG2 is required for disease development in a mouse
model of cutaneous leishmaniasis
As down-regulation of LABCG2 function decreased the in vitro
macrophage infectivity of metacyclic parasites, we analysed
whether this defect was correlated with a lower in vivo virulence
of the parasites using a mouse model of cutaneous leishmaniasis.
Thus, susceptible female BALB/c mice were infected with 104
metacyclics purified from control and LABCG2K/M parasites by
footpad inoculation. As we had previously observed during the
assays to cure LABCG2K/M parasites for the plasmid pUCNeo-
plusLABCG2K/M (reverted line) that the defect on the external-
ization of NBD-PS remained unaltered for at least five weeks in
the absence of antibiotic pressure, we were able to use transfected
parasites for this model. After infection, the measure of inflam-
mation and the development of skin lesions in the footpad with
time were monitored weekly up to a maximum of five weeks. At
this time, control animals had to be sacrificed due to the severity of
the lesions. Mice infected with control parasites showed progres-
sive inflammation and lesion pathology after the first two weeks
(Fig. 6A–C), whereas mice infected with LABCG2K/M parasites
showed no detectable lesions pathology at any time, and presented
significantly lower footpad inflammation (Fig. 6A–C). As observed
in Fig. 6B, the curve for footpad lesion size is the same for non-
infected control animals and for the animals infected with
LABCG2K/M L. major metacyclic parasites, which shows no
lesions during the time of the infection assay.
Additionally, we decided to determine whether these infected
mice presented parasites in different target tissues and whether these
parasites maintained the expression of LABCG2K/M and increased
NBD-PS accumulation. Thus, at the indicated time, mice were
euthanized and their footpad, spleen and lymph nodes collected for
parasite isolation following the limiting dilution assay. As can be
seen from Fig. 6D–E, a lower parasite burden was recovered from
the footpad of mice infected with the LABCG2K/M parasites
compared to the control mice (Fig. 6D), and no parasites were
isolated from the spleen or lymph nodes of mice infected with the
LABCG2K/M parasites (Fig. 6E) after one week of in vitro culture.
Moreover, we confirmed by RT-PCR that the mutant
LABCG2K/M gene was still expressed in parasites isolated from
Figure 4. Leishmania LABCG2K/M parasites present resistance to papuamide B. Sensitivity of control and LABCG2K/M parasites to the PS-
binding peptide papuamide B (A), PE-binding peptide Ro09-0198 (B) and amphotericin B (C). Logarithmic-phase promastigotes were diluted to 106/
mL in RPMI 10% hiFBS containing different concentrations of these peptides; after 72 h, cell viability was analysed by a MTT analysis as described in
Materials and Methods. Results represent the means 6 SD of four independent duplicated experiments. * P,0.05 vs. control parasites.
doi:10.1371/journal.pntd.0002179.g004
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the footpad of mice infected with the LABCG2K/M parasites
(Fig. 7A), and that its phenotype of increased NBD-PS accumula-
tion remained unaltered (Fig. 7B). To confirm that the loss of
virulence exhibited by the mutant line was due to the expression of
LABCG2K/M, these experiments were repeated with a second line
of LABCG2K/M parasites generated from an independent trans-
fection event. The results of this study were similar to those
described above (Appendix in Supporting information, Fig. S8 ),
thus indicating that the dramatic differences in the virulence of
LABCG2K/M parasites were due to down-regulation of LABCG2
function and suggesting that the Leishmania LABCG2 gene is crucial
for disease development.
Discussion
The exposure of PS on their cell surface is one of the
mechanisms known to be used by Leishmania amastigotes and
metacyclic promastigotes to infect host macrophages and to
Figure 5. LABCG2K/M parasites are less infective to mouse peritoneal macrophages. Infection of mouse peritoneal macrophages with
stationary Leishmania promastigotes from control and LABCG2K/M parasites was performed as described in Materials and Methods. The percentage of
infected macrophages (A) and the mean number of parasites per macrophage (B) were determined 24 h post-infection. The results represent the
means 6 SD of three independent experiments. *P,0.05 vs. infection level of control parasites. Additionally, the effect of Annexin V-binding on
macrophage infectivity was determined (C) using control and LABCG2K/M stationary parasites incubated in the presence (+) or absence (2) of Annexin
V (0.05 mg/ml6107 stationary promastigotes) for 4 h. The results shown are the means of three independent experiments 6 SD. *P,0.05 untreated
control vs.: Annexin V-treated control, untreated LABCG2K/M parasites and Annexin V-treated LABCG2K/M parasites.
doi:10.1371/journal.pntd.0002179.g005
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inhibit their microbicidal activity [7–9,11,14,16]. PS is usually
asymmetrically distributed in the cell membrane of eukaryotic
cells and is present only in the cytoplasmic leaflet of the plasma
membrane [18]. Although the PS synthesis in Leishmania have
been a matter of intense debate [59,60], in which the growth
state of Leishmania parasites could be the possible discrepancy
factor, it could be concluded that parasites in late logarithmic
phase contain PS.
Figure 6. LABCG2K/M parasites are less infective in a cutaneous leishmaniasis mouse model. Susceptible BALB/c mice were infected with
104 control and LABCG2K/M L. major metacyclic parasites as described in Materials and Methods. Disease development was monitored weekly by
measuring the inflammation (A) and lesion size (B). The pictures in C show the lesion at week 5 post-infection. Parasite burden was determined in
footpad (D) and tissues (E): lymph nodes (LN) and spleen (SP). The results represent the means6 SD of three independent experiments, with 10 mice
per group. Mice were euthanized when the lesion size in controls reached a value of 50–70 mm2. * P,0.05 vs. control parasites; n.d. stands for not
detected.
doi:10.1371/journal.pntd.0002179.g006
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Although the molecular basis for this outward PS translocation
in Leishmania remains unknown, herein we provide experimental
evidence supporting the involvement of a new ABCG half-
transporter (LABCG2) from Leishmania in this process.
Thus, down-regulation of LABCG2 function in L. major upon
expression of an inactive version of the transporter (LABCG2K/M)
diminishes the outward translocation of fluorescent short-chain
analogues of PS (NBD-PS). This dominant-negative phenotype
seems to be specific for the head of PL, as the movement of
fluorescent analogues of PC, PE or SM was not affected. This
substrate specificity contrasts with the broader spectrum of PL
translocated by other lipid floppases [33,36] and flippases [42]
characterized in Leishmania. Similar results were obtained after
expression of LABCG2K/M in L. donovani and L. infantum, thereby
suggesting that the functionality of LABCG2 could be conserved
in Leishmania spp. It should be noted, however, that this phenotype
was not due to an LABCG2-mediated alteration of PL endocytosis
as the internalization of NBD-SM (which is taken up by lipid-
phase endocytosis) was not altered. In addition, Annexin V-Alexa
488 binding assays showed that LABCG2K/M promastigotes in the
stationary phase exposed less endogenous PS than control
parasites. As Annexin V is not entirely specific for PS, despite its
widespread use in labelling it, and could bind to other anionic PL
[60–62], we performed an additional control using papuamide B,
a cytolytic peptide that specifically recognizes PS residues in
biological membranes [54]. The reduced exposure of PS on the
outer face of the plasma membrane in LABCG2K/M parasites was
correlated with an increased resistance to papuamide B. Although
these differences in resistance to papuamide B were not so higher,
such differences were statistically significant and reproducible even
in GFP-LABCG2K/M parasites, considering that extreme changes
in the phospholipid asymmetry of the eukaryotic membranes lead
to cell death [5,22,63]. The differences in Annexin V labelling
between control and LABCG2K/M parasites were not observed
during the log growth-phase of parasites, where the labelling was
very low. This finding is in agreement with previous reports for L.
donovani and L. tropica [14] and suggests that LABCG2-mediated
PS exposure could be induced during metacyclogenesis of the
parasite and is probably maintained in the intracellular amastigote
stage. The constitutive expression of LABCG2 in both life-cycle
stages of L. donovani has been described recently [34]. Although not
discussed in detail in that study, LABCG2 expression seems to be
higher in the amastigote forms than in the log-phase promastigote
forms [34], as would be expected for a protein involved in PS
externalization. In our case, the results have shown that the
expression of LABCG2 increases in the early and late stationary
phase compare with the log phase and this increase would be
involved in the redistribution of PS to the outer leaflet of the
plasma membrane in the metacyclic forms of the parasite. On the
other hand, the localization of LABCG2 at both the flagellar
pocket and the aflagellar pole as well as in intracellular vesicles,
suggests a possible mechanism for PS exposure in Leishmania,
similar to that described for human ABCG2, namely as an
intracellular sterol transporter [64]. It remains possible that
LABCG2 could transfer PS and other factors (as virulent factors)
to the inner leaflet of these vesicles before their fusion with the
plasma membrane at the flagellar pocket, followed by a
redistribution of PS/other factors to the outer leaflet of the plasma
membrane of the parasite (Fig. 8). In the case of LABCG2 K/M,
the content of PS and other factors could be reduced in the
intracellular vesicles and in the outer leaflet of plasma membrane,
consequently influencing in the infectivity and virulence. A similar
situation has been described for the LtrABCA2 transporter of
Leishmania, involved in phospholipid trafficking and localized at the
flagellar pocket and internal vesicles [43]. Additionally, LABCG2
could function as a floppase of PS/other factors due to their
localization in the flagellar pocket of the parasite (Fig. 8).
In addition, the defect in PS externalization produced by down-
regulation of LABCG2 function was found to be correlated with a
significant reduction of the infection of mouse peritoneal
Figure 7. LABCG2K/M parasites isolated from footpad lesions of infected mice retained the increased NBD-PS accumulation
phenotype. (A) RT-PCR gene-expression analysis of wild-type and mutated LABCG2 in control and LABCG2K/M Leishmania parasites. The lower image
shows the expression of GADPH used as internal loading control. RT-PCR was carried out for 35 cycles using RNA isolated from the above parasites
and the products were run in 2% agarose gel. The positions of molecular markers (bp) are indicated on the left. (B) Accumulation of NBD-PS in control
(grey histogram) and LABCG2K/M (uncoloured histogram) parasites. Parasites recovered from the footpad lesions of infected mice were maintained in
culture medium and the stationary promastigotes incubated with the fluorescent phospholipid analogue NBD-PS for 30 min at 28uC. After washing
and back-exchange with BSA, cell-associated fluorescence was measured by flow cytometry analysis as described in Materials and Methods. The
dotted line represents non-labelled parasites.
doi:10.1371/journal.pntd.0002179.g007
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macrophages by LABCG2K/M parasites. This finding agrees with
previous reports [7,14], which showed that PS exposure was
important for macrophage engulfment of the promastigote and
amastigote forms of Leishmania. As suggested [12], we believe that
the only process probably affected would be the phagocytosis and
consequently the variation of PS exposure could not be important
for the interaction; this consideration would explain the observed
differences in % of infected macrophages. Additionally, the
reduced infectivity was not due to changes in the metacyclogenesis
process considering that LABCG2 function does not affect either
expression of the metacyclic marker protein HASPB or the
number of metacyclic promastigotes produced.
Furthermore, the virulent factors LPG and gp63 are probably
not affected by the function of LABCG2, as deduced by the
absence of variations in the expression levels of these surface
molecules, both of which have been suggested that play important
roles in establishment of the infection. However, we cannot
discard the possibility that other unknown factors involved in the
virulence of Leishmania could be transported by LABCG2, and
their expression could be affected in the LABCG2K/M parasites.
The decrease of the in vitro ability to infect macrophages
observed in mutant parasites with a defect in PS exposure was
found to be correlated with lower infectivity in an in vivo mouse
model of cutaneous leishmaniasis, thereby supporting the proposal
that LABCG2 function is required in order to develop the lesion.
The role of the apoptosis-like PS exposure in the establishment of a
Leishmania infection has been widely discussed. One possibility in
this respect is that PS-positive cells do not necessarily die but use
PS exposure, in an apoptosis-mimicking fashion, to infect
macrophages and inhibit their microbicidal activity [8,11,16,65].
The second possibility suggests that PS-positive forms are indeed
‘‘altruistic’’ apoptotic parasites that have been sentenced to death
but are nevertheless required in order that the PS-negative
infective parasites invade the host cell, in a truly cooperative
system [16,66]. Should be noted considered that these experiments
were made using late stationary phase Leishmania parasites, where
they begin to appreciate the apoptotic round shapes described
above. In our case, the experiments were performed using early
stationary phase Leishmania parasites, where rounded apoptotic
forms were not detected. In any case, PS exposure is the relevant
phenotype for macrophages infection and subsequent inactivation
of microbicidal activity in both these scenarios, thereby allowing
parasite persistence in the host [65].
The need for ABC half-transporters such as ABCG proteins to
dimerize in order to reconstitute the ATP-binding sites and
become functional has allowed us to test a dominant-negative
approach to down-regulate LABCG2 function. Dominant-nega-
tive inhibition of mammalian ABCG2 [50,67] and Leishmania
LABCG5 [35] has also been described upon expression of
different mutants of these transporters. Although the inhibition
of homodimeric LABCG2 function is the most likely explanation
for expression of the inactive version of LABCG2, we cannot rule
out the inhibition of other putative partners. Indeed, some ABCG
proteins, such as human ABCG5/8 [68] and Drosophila White,
Brown and Scarlet, work as heterodimers [69]; the latter can even
change the substrate transported as a function of the partner of the
White protein. However, as expression of inactive versions of
LABCG4 [32] and LABCG5 does not affect the translocation of
PS [35] or the infectivity of the parasites, it is more likely that
LABCG2 does not heterodimerize with these other Leishmania
ABCG proteins; it could however dimerize with LABCG1, which
is almost identical in its TMD.
A further attractive alternative could be that truncated
LABCG3, which only includes the conserved Walker B, the
signature motifs and two transmembrane segments and is
expressed at least at mRNA levels [31,34], could dimerize with
Figure 8. Schematic diagram of the localization of LABCG2 in intracellular vesicles and flagellar pocket of Leishmania parasites. It
remains possible that LABCG2 could transfer PS and other factors (as virulent factors) to the inner leaflet of intracellular vesicles before their fusion
with the plasma membrane at the flagellar pocket, followed by a redistribution of PS/other factors to the outer leaflet of the plasma membrane of the
parasite.
doi:10.1371/journal.pntd.0002179.g008
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LABCG2 to produce an inhibitory effect on LABCG2 function.
This could be a novel way to regulate protein function in this
parasite, although further experiments will be required to confirm
this hypothesis.
Finally, LABCG2 belongs to the same subfamily as mammalian
ABCG2, a well-characterized PS transporter [30] that also pumps
drugs conferring a MDR phenotype in cancer cells [70,71]. Others
LABCG proteins, such as LABCG4 and LABCG6, also confer
resistance to leishmanicidal agents [32,33]. Future work in our
group will examine the implication of LABCG2 in drug resistance.
In conclusion, we have provided evidence that strongly suggests
the involvement of Leishmania LABCG2 function in the PS
externalization required for the infection of host macrophages
and development of the disease. Nonetheless, new approaches will
be needed to fully understand the molecular mechanism by which
LABCG2 affects the infectivity and virulence of Leishmania.
Additionally, these findings indicate that LABCG2 could be
considered as a promising drug target for leishmaniasis. Further-
more, as mutant parasites could be isolated from infected mice
despite the absence of lesions, null mutants for LABCG2 could
potentiality be used for live vaccination studies and to understand
the role of LABCG2 in Leishmania pathogenesis.
Supporting Information
Figure S1 (A) Membrane topology model of the Leish-
mania half-transporters LABCG1, LABCG2 and
LABCG3. The nucleotide binding domain (NBD) is located N-
terminal with respect to the transmembrane domain (TMD). The
putative membrane-spanning helices of the TMD are shown as
cylinders passing through the lipid bilayer. The ATPase catalytic
Walker A, Walker B, and the signature motif C localized in the
nucleotide binding domain (NBD) are shown (boxes A, B and C,
respectively). The arrow indicates the catalytic site mutation
(K108M) engineered into the Walker A motif. The topology model
was predicted using TMHMM (http://www.cbs.dtu.dk/services/
TMHMM-2.0/) and TMRPres2D ((http://biophysics.biol.uoa.
gr/TMRPres2D/) softwares. (B) Amino acid sequences and
alignment (Clustal W) of L. major LABCG1, LABCG2 and
LABCG3. Putative transmembrane segments predicted by
TMHMM and TMRPres2D are underlined. The Walker A/
Walker B motifs, and the ABC family signature motif C are boxed.
Identical amino acids present in the three sequences are indicated
by *, the amino acid similarity is indicated by : and weak similar
amino acid are indicated by . . Gaps introduced for the sequence
alignment are indicated by -.
(TIF)
Figure S2 Gene-expression analysis of LABCG2 in
Leishmania lines. (A) Upper panel: gene expression of
LABCG2 by RT-PCR as indicated by the amplified 280 bp
LABCG2 fragment. Lower panel: gene expression of GADPH as
internal loading control. The arrow indicates amplified 227 bp
GADPH fragment. Lane 1: DNA marker phi 174 HaeIII; lane 2:
control parasites; lane 3: LABCG2K/M parasites. RT-PCR was
carried out for 35 cycles using RNA isolated from the above-
mentioned parasites and the products run in 2% agarose gel. (B)
Growth curve of control (black circles) and LABCG2K/M (black
squares) parasites at different time points (24, 48, 72, 96 and
120 h). The results represent the means 6 SD of three
independent experiments.
(TIF)
Figure S3 Protein expression in GFP-LABCG2 and GFP-
LABCG2K/M Leishmania parasites. Immunodetection of
GFP (A) or H2A histone (lower inset) in L. major lines expressing
control GFP (lane 1), GFP-LABCG2 (lane 2) and GFP-
LABCG2K/M (lane 3). Western blot analysis of total proteins
from parasites incubated with antibodies against GFP or H2A
histone, as loading control, at a 1:5000 dilution. The molecular
mass standards (kDa) from Bio-Rad are indicated on the left. (B) L.
major stationary promastigotes transfected with pXG-GFP+ and
LABCG2K/M-GFP were fixed for 10 min in 2% paraformalde-
hyde at 4uC. a and c, Nomarski images of b and d, respectively. b
shows the cytoplasmic localization of the protein GFP and d
corresponds to localization sites of LABCG2K/M-GFP, indicated
by white arrows in the merged images. Scale bar: 5 mm. FP:
flagellar pocket; AP: aflagellar pole. The figure illustrates a
representative parasite of a total population of parasites with a
similar fluorescence pattern.
(TIF);
Figure S4 Fluorescent PS accumulation in Leishmania
parasites. Stationary promastigotes of L. infantum (A) or L.
donovani (B) were incubated with the fluorescent PL analogue
NBD-PS for 30 min at 28uC. After washing and back-exchange
with BSA, cell-associated fluorescence was measured by flow
cytometry analysis. The grey histogram represents control
parasites transfected with the empty vector, the uncoloured
histogram represents parasites expressing LABCG2K/M and the
dotted histogram represents non-labelled cells. The histograms
correspond to a representative experiment from three independent
experiments.
(TIF);
Figure S5 The externalization of endogenous PS in
Leishmania parasites. PS exposure at the outer leaflet of the
parasite plasma membrane was analyzed by flow cytometry using
Annexin V–Alexa 488 in control parasites as described in
Materials and Methods. Controls measurements in the absence
of calcium were included using Annexin V–Alexa 488 plus 8 mM
EGTA. The results shown are representative of three independent
duplicated experiments 6 SD. * P,0.05 vs. control parasites.
(TIF)
Figure S6 LABCG2K/M parasites has not affected its
capacity of binding to macrophages. (A) Binding of control
and LABCG2K/M metacyclic promastigotes to mouse peritoneal
macrophages. Percentage of positive interaction of promastigotes
to macrophages after 4 h interaction was determined by a
fluorescence microscopy analysis counting 100 macrophages/well.
The results represent the means 6 SD of three independent
experiments. (B) Micrograph of double-fluorescence labeling of the
binding of Leishmania control and LABCG2K/M metacyclic
parasites to mouse peritoneal macrophages. Cell Tracker TM
Green-labeled parasites were added (5:1) to mouse peritoneal
macrophages relabeled with FM4-64 (red). a and c, Nomarski
images of b and d, respectively. b and d shows the binding and
intracellular localization of control and LABCG2K/M parasites.
Scale bar: 10 mm. The expression levels of two surface molecules,
LPG (C) and gp63 (D), were determined in control and
LABCG2K/M parasites marked with fluorescein-conjugated ricin
agglutinin that specifically labels LPG (C) and a specific
monoclonal antibody for Leishmania gp63 (D). The fluorescence
intensity was determined by flow cytometry analysis, as described
in Materials and Methods. The data are means of the geometrical
mean channel fluorescence values (g.m.) 6 SD of three
independent experiments versus controls.
(TIF)
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Figure S7 LABCG2K/M Leishmania parasites do not
show defective metacyclogenesis. (A) Control and
LABCG2K/M metacyclic parasites were purified from stationary
promastigotes using negative selection with the lectin PNA, as
described in Materials and Methods. The results represent the
means6 SD of four independent experiments. (B) Analysis by flow
cytometry of the FSC-H of control and LABCG2K/M metacyclic
parasites; right panel shows a Nomarsky micrography of the same
samples. Scale bar: 5 mm. (C) Total cell lysates from stationary
promastigotes were analyzed by Western blotting with an antibody
to the metacyclic protein HASPB. Anti-alpha tubulin antibody
was used as loading control. The positions of molecular marker
(kDa) are indicated on the left.
(TIF)
Figure S8 LABCG2K/M parasites are less infective in a
mouse model of cutaneous leishmaniasis. A second
independent transfection event using control and LABCG2K/M
parasites was inoculated in mice, as described in Materials and
Methods. The inflammation (A), lesion size (B) and parasite
burden in footpad (D) and tissues (E) such as lymph nodes (LN)
and spleen (SP) were determined weekly. The pictures in C show
the lesion at week 5 post-infection. The results represent the means
6 SD of three independent experiments, with 10 mice per group.
Mice were euthanized when the lesion size in controls reached a
value of 50–70 mm2. *P,0.05 vs. control parasites; n.d. stands for
not detected.
(TIF)
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